Noah Greenwald, PhD
Postdoctoral Scholar
Bioengineering
School of Pharmacy

Noah received his Bachelor’s in Biophysics from Harvard University. He then worked at the Broad Institute, where he analyzed DNA sequencing data to identify the genomic drivers that separate low-grade and high-grade brain cancers. Following his work at the Broad, he received his Ph.D in Cancer Biology from Stanford University, where he was co-advised by Mike Angelo and Christina Curtis.

While at Stanford, Noah developed machine learning tools to profile highly-multiplexed imaging data. He then used these tools to characterize the tumor microenvironment in breast cancer patient samples, combining this spatial information with paired DNA and RNA sequencing data to predict patient response to immunotherapy. In the Coyote-Maestas lab, Noah is using deep mutational scanning to understand the cross talk between cancer and immune cells.

Awards

Show all (3) Hide

  • F99/K00 Fellow, National Institutes of Health, National Cancer Institute, 2021-2028
  • F31 Fellow, National Institutes of Health, National Cancer Institute, 2020-2021
  • Lucille P. Markey Biomedical Research Fellow, Stanford University, 2017-2020

Education & Training

Show all (2) Hide

  • PhD Cancer Biology Stanford University 2024
  • BA Biophysics Harvard University 2015

Websites

Show all (1) Hide

Publications (40)

Top publication keywords:
Protein Phosphatase 2CHydralazineSingle-Cell AnalysisPublishingLoss of Function MutationImmunohistochemistryDNA Copy Number VariationsMeningiomaMeningeal NeoplasmsClonal EvolutionGliomaDioxygenasesPituitary NeoplasmsPublicationsImage Processing, Computer-Assisted